QuidelOrtho Corp (QDEL): Depreciation & Amortization
$442.00M
Year ended 2025-12-28
$454.20M
Trailing 12 months to 2026-06-28
+15.9%
3-year compound annual growth
+55.4%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-28 | $442.00M | -2.5% | 2026-02-19, From 2024-12-30 |
| 2024-12-29 | $453.40M | -0.8% | 2026-02-19, From 2024-01-01 |
| 2023-12-31 | $457.20M | +61.2% | 2026-02-19, From 2023-01-02 |
| 2023-01-01, Fiscal 2022 | $283.60M | +438.1% | 2025-02-27, From 2022-01-03 |
| 2022-01-02, Fiscal 2021 | $52.70M | +8.0% | 2024-08-01, From 2021-01-04 |
| 2021-01-03, Fiscal 2020 | $48.80M | n/a | 2023-02-23, From 2019-12-30 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | 2025-12-28 | $442.00M | -2.5% |
| Idexx Laboratories Inc (IDXX) | 2025-12-31 | $145.18M | +11.7% |
| Lantheus Holdings, Inc. (LNTH) | 2025-12-31 | $70.10M | +8.5% |
| Neogen Corp (NEOG) | 2026-05-31 | $116.30M | -2.7% |
| Myriad Genetics Inc (MYGN) | 2025-12-31 | $53.70M | -12.3% |
| Intellia Therapeutics, Inc. (NTLA) | 2025-12-31 | $9.77M | -5.0% |
| Alpha Teknova, Inc. (TKNO) | 2025-12-31 | $6.34M | -3.6% |
| Immucell Corp (ICCC) | 2025-12-31 | $2.78M | +2.0% |
| Aspira Women's Health Inc. (AWHL) | 2025-12-31 | $112.0K | +21.7% |
Compare QDEL, IDXX, LNTH, NEOG side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗